Passive transfer of IgG anti-GM1 antibodies impairs peripheral nerve repair.

PubWeight™: 0.85‹?›

🔗 View Article (PMC 3038609)

Published in J Neurosci on July 14, 2010

Authors

Pablo H Lopez1, Gang Zhang, Jiangyang Zhang, Helmar C Lehmann, John W Griffin, Ronald L Schnaar, Kazim A Sheikh

Author Affiliations

1: Department of Neurology, The Johns Hopkins University, Baltimore, Maryland 21287, USA.

Articles cited by this

Guillain-Barré syndrome. Lancet (2005) 8.73

The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis. Medicine (Baltimore) (1969) 4.72

Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis. Neurology (1990) 3.91

Peripheral neuropathies and anti-glycolipid antibodies. Brain (2002) 3.04

Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain (1995) 2.61

Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Ann Neurol (1998) 2.47

Lipid microarrays identify key mediators of autoimmune brain inflammation. Nat Med (2005) 2.31

Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice. N Engl J Med (1977) 2.23

An acute axonal form of Guillain-Barré polyneuropathy. Brain (1986) 2.20

Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects. Proc Natl Acad Sci U S A (1999) 1.95

Conduction block and denervation in Guillain-Barré polyneuropathy. Brain (1984) 1.94

The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders. Ann Neurol (1993) 1.92

Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barré syndrome patients mimic human gangliosides in structure. Infect Immun (1994) 1.75

Preceding infections, immune factors, and outcome in Guillain-Barré syndrome. Neurology (2001) 1.74

Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features. Q J Med (1993) 1.67

Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome. Ann Neurol (1996) 1.58

Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan. Ann Neurol (2000) 1.50

B cells and antibodies in CNS demyelinating disease. J Neuroimmunol (2001) 1.50

Mass spectrometry of carbohydrate-containing biopolymers. Methods Enzymol (1994) 1.49

Thermodynamics of intersubunit interactions in cholera toxin upon binding to the oligosaccharide portion of its cell surface receptor, ganglioside GM1. Biochemistry (1989) 1.43

IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome. Ann Neurol (1998) 1.37

Localization of major gangliosides in the PNS: implications for immune neuropathies. Brain (2002) 1.34

Quantitative analysis of bacterial toxin affinity and specificity for glycolipid receptors by surface plasmon resonance. J Biol Chem (1997) 1.30

A new method for purification of anti-glycosphingolipid antibody. Avian anti-hematoside (NeuGc) antibody. J Biochem (1983) 1.28

Clinical presentation and outcome of Guillain-Barré and related syndromes in relation to anti-ganglioside antibodies. J Neurol Sci (1999) 1.25

Circulating autoantibodies to the 200,000-dalton protein of neurofilaments in the serum of healthy individuals. Science (1985) 1.16

Campylobacter jejuni lipopolysaccharides in Guillain-Barré syndrome: molecular mimicry and host susceptibility. Neurology (1998) 1.14

Cross-linking of GM1 ganglioside by galectin-1 mediates regulatory T cell activity involving TRPC5 channel activation: possible role in suppressing experimental autoimmune encephalomyelitis. J Immunol (2009) 1.13

Passive immunization with anti-ganglioside antibodies directly inhibits axon regeneration in an animal model. J Neurosci (2007) 1.07

Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy. Neurology (1999) 1.05

The distribution of ganglioside-like moieties in peripheral nerves. Brain (1999) 1.05

Immunoglobulin G-class mouse monoclonal antibodies to major brain gangliosides. Anal Biochem (2002) 1.04

Cross-reactive antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in patients with Guillain-Barré or Miller Fisher syndrome. J Infect Dis (1997) 1.03

Membrane lipids of human peripheral nerve and spinal cord. Biochim Biophys Acta (1992) 1.03

Overexpression of GD1a ganglioside sensitizes motor nerve terminals to anti-GD1a antibody-mediated injury in a model of acute motor axonal neuropathy. J Neurosci (2005) 1.02

Antibodies to acidic glycolipids in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. J Neurol Sci (1992) 1.02

Magnetic resonance imaging of mouse skeletal muscle to measure denervation atrophy. Exp Neurol (2008) 1.02

Increased uptake and transport of cholera toxin B-subunit in dorsal root ganglion neurons after peripheral axotomy: possible implications for sensory sprouting. J Comp Neurol (1999) 1.00

The neuropathic potential of anti-GM1 autoantibodies is regulated by the local glycolipid environment in mice. J Clin Invest (2009) 1.00

An anti-ganglioside antibody-secreting hybridoma induces neuropathy in mice. Ann Neurol (2004) 1.00

Two patterns of clinical recovery in Guillain-Barré syndrome with IgG anti-GM1 antibody. Neurology (1998) 0.92

Transganglionic transport of choleragenoid by capsaicin-sensitive C-fibre afferents to the substantia gelatinosa of the spinal dorsal horn after peripheral nerve section. Neuroscience (2003) 0.91

Sprouting from chicken embryo dorsal root ganglia induced by nerve growth factor is specifically inhibited by affinity-purified antiganglioside antibodies. Proc Natl Acad Sci U S A (1982) 0.90

Slowing of the rate of axonal regeneration during growth and maturation. Exp Neurol (1979) 0.90

Structural requirements of anti-GD1a antibodies determine their target specificity. Brain (2008) 0.89

Human IgM anti-GM1 autoantibodies modulate intracellular calcium homeostasis in neuroblastoma cells. J Neuroimmunol (2001) 0.86

High affinity as a disease determinant factor in anti-GM(1) antibodies: comparative characterization of experimentally induced vs. disease-associated antibodies. J Neuroimmunol (2002) 0.84

Antibodies to gangliosides inhibit goldfish optic nerve regeneration in vivo. J Neurosci Res (1984) 0.83

Serum and CSF anti-GM1 antibodies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. J Neurol Sci (1993) 0.83

Temporal profile of anti-ganglioside antibodies and their relation to clinical parameters and treatment in Guillain-Barré syndrome. J Neurol Sci (2001) 0.83

Widespread dispersal of cholera toxin subunit b to brain and spinal cord neurons following systemic delivery. Exp Neurol (2002) 0.82

IgM anti-GM1 antibodies in the Guillain-Barré syndrome: a serological predictor of the clinical course. J Neuroimmunol (1997) 0.82

Anti-GM1 antibody IgG subclass: a clinical recovery predictor in Guillain-Barré syndrome. Neurology (2003) 0.81

Synthesis and characterization of lyso-GM3 (II3Neu5Ac Lactosyl sphingosine), de-N-acetyl-GM3 (II3NeuNH2 lactosyl Cer), and related compounds. Carbohydr Res (1988) 0.81

An update on pathobiologic roles of anti-glycan antibodies in Guillain-Barré syndrome. F1000 Biol Rep (2010) 0.80

The role of calcium influx in cellular proliferation induced by interaction of endogenous ganglioside GM1 with the B subunit of cholera toxin. Biochim Biophys Acta (1995) 0.80

Association of anti-GM1 antibodies but not of anti-cytomegalovirus, Campylobacter jejuni and Helicobacter pylori IgG, with a poor outcome in Guillain-Barré syndrome. J Neurol Sci (2003) 0.79

Anti-GM1 ganglioside antibodies cloned from autoimmune neuropathy patients show diverse binding patterns in the rodent nervous system. J Neuropathol Exp Neurol (1996) 0.77

Electrophysiological studies in Guillain-Barré syndrome: correlation with antibodies to GM1, GD1B and Campylobacter jejuni. J Neurol (1995) 0.77

Antiganglioside antibodies inhibit neuritic outgrowth from regenerating goldfish retinal explants. J Neurochem (1982) 0.77

Normal human plasma contains antibodies that specifically block neuropathy-associated human anti-GM1 IgG-antibodies. J Neuroimmunol (2000) 0.77

Inhibition of conditioned media-mediated neuritogenesis of sensory ganglia by monoclonal antibodies to GM1 ganglioside. Brain Res (1988) 0.76

Articles by these authors

Reproducibility of quantitative tractography methods applied to cerebral white matter. Neuroimage (2007) 7.14

Stereotaxic white matter atlas based on diffusion tensor imaging in an ICBM template. Neuroimage (2008) 6.58

Principles of diffusion tensor imaging and its applications to basic neuroscience research. Neuron (2006) 6.51

Tract probability maps in stereotaxic spaces: analyses of white matter anatomy and tract-specific quantification. Neuroimage (2007) 5.23

Atlas-based whole brain white matter analysis using large deformation diffeomorphic metric mapping: application to normal elderly and Alzheimer's disease participants. Neuroimage (2009) 3.74

DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Am J Hum Genet (2004) 3.72

NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts. Stem Cells (2010) 3.42

Human brain white matter atlas: identification and assignment of common anatomical structures in superficial white matter. Neuroimage (2008) 2.86

A hierarchical NGF signaling cascade controls Ret-dependent and Ret-independent events during development of nonpeptidergic DRG neurons. Neuron (2007) 2.83

Impaired synaptic vesicle release and immaturity of neuromuscular junctions in spinal muscular atrophy mice. J Neurosci (2009) 2.71

White and gray matter development in human fetal, newborn and pediatric brains. Neuroimage (2006) 2.55

Filopodia are required for cortical neurite initiation. Nat Cell Biol (2007) 2.49

Analysis of noise effects on DTI-based tractography using the brute-force and multi-ROI approach. Magn Reson Med (2004) 2.35

Glycan array screening reveals a candidate ligand for Siglec-8. J Biol Chem (2004) 2.24

Atlas-guided tract reconstruction for automated and comprehensive examination of the white matter anatomy. Neuroimage (2010) 2.21

DTI tractography based parcellation of white matter: application to the mid-sagittal morphology of corpus callosum. Neuroimage (2005) 2.13

High resolution diffusion tensor imaging of axonal damage in focal inflammatory and demyelinating lesions in rat spinal cord. Brain (2007) 2.03

Ena/VASP Is Required for neuritogenesis in the developing cortex. Neuron (2007) 2.01

E-selectin receptors on human leukocytes. Blood (2008) 1.99

An MRI-based atlas and database of the developing mouse brain. Neuroimage (2010) 1.99

Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets. Nat Med (2011) 1.97

The time course of epidermal nerve fibre regeneration: studies in normal controls and in people with diabetes, with and without neuropathy. Brain (2004) 1.90

Atlas-based analysis of neurodevelopment from infancy to adulthood using diffusion tensor imaging and applications for automated abnormality detection. Neuroimage (2010) 1.89

The NPro product of bovine viral diarrhea virus inhibits DNA binding by interferon regulatory factor 3 and targets it for proteasomal degradation. J Virol (2006) 1.84

Robo1 regulates the development of major axon tracts and interneuron migration in the forebrain. Development (2006) 1.83

Diffusion tensor magnetic resonance imaging of Wallerian degeneration in rat spinal cord after dorsal root axotomy. J Neurosci (2009) 1.79

Diabetes and driving. Diabetes Care (2012) 1.66

Anatomical characterization of human fetal brain development with diffusion tensor magnetic resonance imaging. J Neurosci (2009) 1.66

Axonal growth and guidance defects in Frizzled3 knock-out mice: a comparison of diffusion tensor magnetic resonance imaging, neurofilament staining, and genetically directed cell labeling. J Neurosci (2006) 1.64

Gangliosides in cell recognition and membrane protein regulation. Curr Opin Struct Biol (2009) 1.57

Inhibition of beta interferon transcription by noncytopathogenic bovine viral diarrhea virus is through an interferon regulatory factor 3-dependent mechanism. J Virol (2002) 1.56

Gangliosides are functional nerve cell ligands for myelin-associated glycoprotein (MAG), an inhibitor of nerve regeneration. Proc Natl Acad Sci U S A (2002) 1.54

Carcinoembryonic antigen and CD44 variant isoforms cooperate to mediate colon carcinoma cell adhesion to E- and L-selectin in shear flow. J Biol Chem (2008) 1.51

Dysfunction of nodes of Ranvier: a mechanism for anti-ganglioside antibody-mediated neuropathies. Exp Neurol (2011) 1.51

Diffusion tensor imaging to assess axonal regeneration in peripheral nerves. Exp Neurol (2009) 1.48

Dynamic simulation and preliminary finite element analysis of gunshot wounds to the human mandible. Injury (2011) 1.43

Direct binding between BubR1 and B56-PP2A phosphatase complexes regulate mitotic progression. J Cell Sci (2013) 1.42

The influence of RAMP1 overexpression on CGRP-induced osteogenic differentiation in MG-63 cells in vitro: an experimental study. J Cell Biochem (2013) 1.42

Metabolic cytometry. Glycosphingolipid metabolism in single cells. Anal Chem (2007) 1.41

Spatiotemporal maturation patterns of murine brain quantified by diffusion tensor MRI and deformation-based morphometry. Proc Natl Acad Sci U S A (2005) 1.41

Schwann cell chemokine receptors mediate HIV-1 gp120 toxicity to sensory neurons. Ann Neurol (2003) 1.39

The transcription factor Zfp423/OAZ is required for cerebellar development and CNS midline patterning. Dev Biol (2007) 1.39

Selectin ligand expression regulates the initial vascular interactions of colon carcinoma cells: the roles of CD44v and alternative sialofucosylated selectin ligands. J Biol Chem (2006) 1.39

Glial cell line-derived neurotrophic factor alters axon schwann cell units and promotes myelination in unmyelinated nerve fibers. J Neurosci (2003) 1.38

Extraordinary photoluminescence and strong temperature/angle-dependent Raman responses in few-layer phosphorene. ACS Nano (2014) 1.38

Degeneration of myelinated efferent fibers induces spontaneous activity in uninjured C-fiber afferents. J Neurosci (2002) 1.36

Three-dimensional diffusion tensor microimaging for anatomical characterization of the mouse brain. Magn Reson Med (2010) 1.34

Imaging, anatomical, and molecular analysis of callosal formation in the developing human fetal brain. Anat Rec A Discov Mol Cell Evol Biol (2006) 1.32

Myelin-associated glycoprotein and complementary axonal ligands, gangliosides, mediate axon stability in the CNS and PNS: neuropathology and behavioral deficits in single- and double-null mice. Exp Neurol (2005) 1.32

Sialic acids in the brain: gangliosides and polysialic acid in nervous system development, stability, disease, and regeneration. Physiol Rev (2014) 1.32

Delayed mGluR5 activation limits neuroinflammation and neurodegeneration after traumatic brain injury. J Neuroinflammation (2012) 1.31

Axonal protective effects of the myelin-associated glycoprotein. J Neurosci (2009) 1.29

Lectin microarrays identify cell-specific and functionally significant cell surface glycan markers. Glycobiology (2008) 1.28

Variant isoforms of CD44 are P- and L-selectin ligands on colon carcinoma cells. FASEB J (2005) 1.28

Diabetes and employment. Diabetes Care (2013) 1.28

Preparation of high-quality next-generation sequencing libraries from picogram quantities of target DNA. Genome Res (2011) 1.24

Quantitative analysis of brain pathology based on MRI and brain atlases--applications for cerebral palsy. Neuroimage (2010) 1.24

Podocalyxin-like protein is an E-/L-selectin ligand on colon carcinoma cells: comparative biochemical properties of selectin ligands in host and tumor cells. Am J Physiol Cell Physiol (2008) 1.23

Membrane redistribution of gangliosides and glycosylphosphatidylinositol-anchored proteins in brain tissue sections under conditions of lipid raft isolation. Biochim Biophys Acta (2005) 1.22

Denervation of skin in neuropathies: the sequence of axonal and Schwann cell changes in skin biopsies. Brain (2007) 1.21

DNA sensing by silicon nanowire: charge layer distance dependence. Nano Lett (2008) 1.20

Gangliosides and Nogo receptors independently mediate myelin-associated glycoprotein inhibition of neurite outgrowth in different nerve cells. J Biol Chem (2007) 1.19

beta1-integrin mediates myelin-associated glycoprotein signaling in neuronal growth cones. Mol Brain (2008) 1.19

Intact cell adhesion to glycan microarrays. Glycobiology (2003) 1.17

A novel solid-state thermal rectifier based on reduced graphene oxide. Sci Rep (2012) 1.17

Transplanted neural stem cells promote axonal regeneration through chronically denervated peripheral nerves. Exp Neurol (2004) 1.13

Nine orders of magnitude dynamic range: picomolar to millimolar concentration measurement in capillary electrophoresis with laser induced fluorescence detection employing cascaded avalanche photodiode photon counters. Anal Chem (2011) 1.12

Characterization of a novel wheat NAC transcription factor gene involved in defense response against stripe rust pathogen infection and abiotic stresses. Mol Biol Rep (2010) 1.12

Eosinophil-selective binding and proapoptotic effect in vitro of a synthetic Siglec-8 ligand, polymeric 6'-sulfated sialyl Lewis x. J Pharmacol Exp Ther (2009) 1.12

Synthesis of reference standards to enable single cell metabolomic studies of tetramethylrhodamine-labeled ganglioside GM1. Carbohydr Res (2006) 1.11

Peroxisome-proliferator-activated receptor gamma coactivator 1 α contributes to dysmyelination in experimental models of Huntington's disease. J Neurosci (2011) 1.09

Delayed neural network degeneration after neonatal hypoxia-ischemia. Ann Neurol (2008) 1.08

Molecular identification of GD3 as a suppressor of the innate immune response in ovarian cancer. Cancer Res (2012) 1.08

Polarity-reversed robust carrier mobility in monolayer MoS₂ nanoribbons. J Am Chem Soc (2014) 1.08

Chemokines and chemokine receptors in inflammatory demyelinating neuropathies: a central role for IP-10. Brain (2002) 1.08

Small-molecule TrkB receptor agonists improve motor function and extend survival in a mouse model of Huntington's disease. Hum Mol Genet (2013) 1.08

Epidermal reinnervation after intracutaneous axotomy in man. J Comp Neurol (2003) 1.08

Potent glycan inhibitors of myelin-associated glycoprotein enhance axon outgrowth in vitro. J Biol Chem (2005) 1.08

Sialidase enhances spinal axon outgrowth in vivo. Proc Natl Acad Sci U S A (2006) 1.08

Probing mouse brain microstructure using oscillating gradient diffusion MRI. Magn Reson Med (2011) 1.07

Passive immunization with anti-ganglioside antibodies directly inhibits axon regeneration in an animal model. J Neurosci (2007) 1.07

Peripheral neuropathy: assessment of proximal nerve integrity by diffusion tensor imaging. Muscle Nerve (2013) 1.06

Multi-modal MRI analysis with disease-specific spatial filtering: initial testing to predict mild cognitive impairment patients who convert to Alzheimer's disease. Front Neurol (2011) 1.06

Reduced BACE1 activity enhances clearance of myelin debris and regeneration of axons in the injured peripheral nervous system. J Neurosci (2011) 1.06

Structural MRI detects progressive regional brain atrophy and neuroprotective effects in N171-82Q Huntington's disease mouse model. Neuroimage (2011) 1.05

Characterization of expression of glycan ligands for Siglec-F in normal mouse lungs. Am J Respir Cell Mol Biol (2010) 1.05

Differential distribution of HLA-DQ beta/DR beta epitopes in the two forms of Guillain-Barré syndrome, acute motor axonal neuropathy and acute inflammatory demyelinating polyneuropathy (AIDP): identification of DQ beta epitopes associated with susceptibility to and protection from AIDP. J Immunol (2003) 1.05

Diffusion tensor magnetic resonance imaging and tract-tracing analysis of Probst bundle structure in Netrin1- and DCC-deficient mice. J Neurosci (2007) 1.05

Ultralow thermal conductivity of isotope-doped silicon nanowires. Nano Lett (2007) 1.05

Immunoglobulin G-class mouse monoclonal antibodies to major brain gangliosides. Anal Biochem (2002) 1.04

Three-dimensional imaging of the mouse neurovasculature with magnetic resonance microscopy. PLoS One (2011) 1.04

Myelin-associated glycoprotein (Siglec-4) expression is progressively and selectively decreased in the brains of mice lacking complex gangliosides. Glycobiology (2004) 1.04